Insider filing · BBIO
Jennifer E. Cook
Director
profile →
BridgeBio Pharma, Inc.
BBIO · Healthcare · 71 filings in 24 months
ticker →
Jennifer E. Cook sold $6.0M of BridgeBio Pharma (BBIO)
Executed Jun 15, disclosed Jun 17, 2 days later.
Value, as filed
$6.0M
90,240 sh across 2 lots
Executed
Jun 15
the trade date, as filed
Disclosed
Jun 17
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JCJennifer E. Cook (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $13.2M of BBIO (148,589 sh across 2 lots, as filed), executed Jul 9.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jennifer E. Cook in BBIO
BBIOSALE
BridgeBio Pharma, Inc.
$13.2M148,589 sh across 2 lots
Exec Jul 9
Filed Jul 13 · 4:40 PM ET BBIOSALE BridgeBio Pharma, Inc. $2.8M
39,363 sh across 2 lots
Exec Jun 23
Filed Jun 24 · 5:30 PM ET